142 related articles for article (PubMed ID: 7673355)
1. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex.
Stefansson S; Kounnas MZ; Henkin J; Mallampalli RK; Chappell DA; Strickland DK; Argraves WS
J Cell Sci; 1995 Jun; 108 ( Pt 6)():2361-8. PubMed ID: 7673355
[TBL] [Abstract][Full Text] [Related]
2. Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes.
Moestrup SK; Nielsen S; Andreasen P; Jørgensen KE; Nykjaer A; Røigaard H; Gliemann J; Christensen EI
J Biol Chem; 1993 Aug; 268(22):16564-70. PubMed ID: 8344937
[TBL] [Abstract][Full Text] [Related]
3. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
Nykjaer A; Kjøller L; Cohen RL; Lawrence DA; Garni-Wagner BA; Todd RF; van Zonneveld AJ; Gliemann J; Andreasen PA
J Biol Chem; 1994 Oct; 269(41):25668-76. PubMed ID: 7929271
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.
Willnow TE; Goldstein JL; Orth K; Brown MS; Herz J
J Biol Chem; 1992 Dec; 267(36):26172-80. PubMed ID: 1464627
[TBL] [Abstract][Full Text] [Related]
5. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
[TBL] [Abstract][Full Text] [Related]
6. Degradation of urokinase plasminogen activator (UPA) in endometrial stromal cells requires both the UPA receptor and the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor.
Casslén B; Gustavsson B; Angelin B; Gåfvels M
Mol Hum Reprod; 1998 Jun; 4(6):585-93. PubMed ID: 9665342
[TBL] [Abstract][Full Text] [Related]
7. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin.
Kounnas MZ; Loukinova EB; Stefansson S; Harmony JA; Brewer BH; Strickland DK; Argraves WS
J Biol Chem; 1995 Jun; 270(22):13070-5. PubMed ID: 7768901
[TBL] [Abstract][Full Text] [Related]
8. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
Andersen OM; Petersen HH; Jacobsen C; Moestrup SK; Etzerodt M; Andreasen PA; Thøgersen HC
Biochem J; 2001 Jul; 357(Pt 1):289-96. PubMed ID: 11415462
[TBL] [Abstract][Full Text] [Related]
9. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex.
Heegaard CW; Simonsen AC; Oka K; Kjøller L; Christensen A; Madsen B; Ellgaard L; Chan L; Andreasen PA
J Biol Chem; 1995 Sep; 270(35):20855-61. PubMed ID: 7657671
[TBL] [Abstract][Full Text] [Related]
10. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
Stefansson S; Lawrence DA; Argraves WS
J Biol Chem; 1996 Apr; 271(14):8215-20. PubMed ID: 8626514
[TBL] [Abstract][Full Text] [Related]
12. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.
Argraves KM; Battey FD; MacCalman CD; McCrae KR; Gåfvels M; Kozarsky KF; Chappell DA; Strauss JF; Strickland DK
J Biol Chem; 1995 Nov; 270(44):26550-7. PubMed ID: 7592875
[TBL] [Abstract][Full Text] [Related]
13. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.
Moestrup SK; Cui S; Vorum H; Bregengård C; Bjørn SE; Norris K; Gliemann J; Christensen EI
J Clin Invest; 1995 Sep; 96(3):1404-13. PubMed ID: 7544804
[TBL] [Abstract][Full Text] [Related]
14. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.
Nykjaer A; Petersen CM; Møller B; Jensen PH; Moestrup SK; Holtet TL; Etzerodt M; Thøgersen HC; Munch M; Andreasen PA
J Biol Chem; 1992 Jul; 267(21):14543-6. PubMed ID: 1378833
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
Horn IR; Moestrup SK; van den Berg BM; Pannekoek H; Nielsen MS; van Zonneveld AJ
J Biol Chem; 1995 May; 270(20):11770-5. PubMed ID: 7538122
[TBL] [Abstract][Full Text] [Related]
16. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase.
Kounnas MZ; Henkin J; Argraves WS; Strickland DK
J Biol Chem; 1993 Oct; 268(29):21862-7. PubMed ID: 7691818
[TBL] [Abstract][Full Text] [Related]
17. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
[TBL] [Abstract][Full Text] [Related]
18. Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro.
Niemeier A; Willnow T; Dieplinger H; Jacobsen C; Meyer N; Hilpert J; Beisiegel U
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):552-61. PubMed ID: 10073957
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
Bu G; Maksymovitch EA; Schwartz AL
J Biol Chem; 1993 Jun; 268(17):13002-9. PubMed ID: 8389767
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein 330, a member of the low density lipoprotein receptor family, binds lipoprotein lipase in vitro.
Kounnas MZ; Chappell DA; Strickland DK; Argraves WS
J Biol Chem; 1993 Jul; 268(19):14176-81. PubMed ID: 7686151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]